Drug intelligence / Profile preview

eczema calming lotion

Development stage
Unknown
Lead developer
Unilever
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Eczema calming lotion is a topical emollient formulation developed by Unilever, specifically designed for the management of atopic dermatitis (eczema). The product contains a combination of petroleum jelly (petrolatum), fatty acids, and colloidal oatmeal, which work synergistically to repair and strengthen the skin's epidermal barrier. Its mechanism of action involves promoting the maturation of corneocytes by facilitating the peripheral redistribution of corneodesmosin (CDSN) and increasing the length and organization of intercellular lipid lamellae (ICLL) within the stratum corneum. Clinical data indicates that the lotion helps normalize ceramide profiles, particularly by increasing the levels of long-chain ceramides, thereby reducing transepidermal water loss and improving skin hydration in both lesional and non-lesional AD-prone skin.

Brand names
Vaseline Eczema CalmingVaseline Intensive Care Eczema Calming
Other names
eczema calming lotion containing petroleum jelly, fatty acids, and colloidal oatmeal

Beyond the preview

Go deeper on eczema calming lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eczema calming lotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call